Central nervous system (CNS) disorders (eg, multiple sclerosis, Alzheimer's disease, etc.)
represent a growing public health issue, primarily due to the increased life expectancy and …

The pulmonary route of administration has proven to be effective in local and systemic
delivery of miscellaneous drugs and biopharmaceuticals to treat pulmonary and non …

Nanoparticle-based therapeutics have been used in pulmonary formulations to enhance
delivery of poorly water-soluble drugs, protect drugs against degradation and achieve …

Despite the wide use of antibiotics, bacterial infection is still one of the leading causes of
hospitalization and mortality. The clinical failure of antibiotic therapy is linked with low …

Research in pulmonary drug delivery has focused mainly on new particle or device
technologies to improve the aerosol generation and pulmonary deposition of inhaled drugs …

The efficacy of pharmaceutical aerosols relates to its deposition in the clinically relevant
regions of the lungs, which can be assessed by in vivo lung deposition studies. Dry powder …

Thermostable dry powder inhaler (DPI) formulations with high aerosol performance are
attractive inhalable solid dosage forms for local treatment of inflammatory lung diseases. We …

Drug delivery to the lungs is an effective way of targeting inhaled therapeutic aerosols and
treating obstructive airway diseases, such as asthma and chronic obstructive pulmonary …

Pulmonary drug delivery is currently the focus of accelerated research and development
because of the potential to produce maximum therapeutic benefit to patients by directly …

During the last decades, the term “drug delivery systems”(DDSs) has almost fully replaced
previously used terms, such as “dosage forms”, in an attempt to emphasize the importance …